课题基金 / 基金详情

The contractor will develop COMPASS, a device-agnostic platform that measures and

The contractor will develop COMPASS, a device-agnostic platform that measures and
承包商将开发 COMPASS,这是一个与设备无关的平台,用于测量和
批准号:
8749814
负责人:
Fahd Albinali
金额:
$20.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-20 至 2014-06-19

项目摘要

项目成果

Fahd Albinali的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This proposal was submitted under the SBIR Fast-track process. In Phase I, the primary purpose is to develop COMPASS; a device-agnostic platform that measures and delivers customizable, evidence-informed rehabilitation services to cancer survivors/patients using mobile phones/tablets, objective measurement sensors (such as accelerometers, gyroscopes, electro-dermal response for affect, indoor location) and self-reported data.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IGF::OT::IGF R&D- MEDICAL: BIOMEDICAL (BASIC RESEARCH)
  • 批准号:
    9148277
  • 项目类别:
  • 资助金额:
    $149.93万
  • 财政年份:
    2015
  • 负责人:
    Fahd Albinali
  • 依托单位:
TOPIC 296 PHASE II; A SYSTEM FOR ENCOURAGING ADOPTION OF NEW METHODS FOR ACTIVIT
  • 批准号:
    8762510
  • 项目类别:
  • 资助金额:
    $94.82万
  • 财政年份:
    2013
  • 负责人:
    Fahd Albinali
  • 依托单位:
海外基金